These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16967458)

  • 1. Malignancies in organ transplant recipients.
    Kauffman HM
    J Surg Oncol; 2006 Oct; 94(5):431-3. PubMed ID: 16967458
    [No Abstract]   [Full Text] [Related]  

  • 2. Infectious complications of immunosuppressive medications in organ transplant recipients.
    Green M; Michaels MG
    Pediatr Infect Dis J; 2007 May; 26(5):443-4. PubMed ID: 17468657
    [No Abstract]   [Full Text] [Related]  

  • 3. Posttransplant lymphoproliferative disease of donor origin.
    Nalesnik MA
    Arch Pathol Lab Med; 1997 Jul; 121(7):665-6. PubMed ID: 9240898
    [No Abstract]   [Full Text] [Related]  

  • 4. Pediatric transplant grand rounds.
    Benfield MR; Harmon WE
    Pediatr Transplant; 1997 Aug; 1(1):65-72. PubMed ID: 10084789
    [No Abstract]   [Full Text] [Related]  

  • 5. Post-transplant lymphoproliferative disorders.
    Chetty R; Dada MA
    S Afr J Surg; 1998 Feb; 36(1):4, 6, 8-9. PubMed ID: 9601824
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary central nervous system post-transplantation lymphoproliferative disorder.
    Dierickx D; Tousseyn T; Verhoef G
    Cancer; 2010 Jul; 116(14):3521; author reply 3521-2. PubMed ID: 20564159
    [No Abstract]   [Full Text] [Related]  

  • 7. Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology.
    Valantine H
    J Heart Lung Transplant; 2007 Jun; 26(6):557-64. PubMed ID: 17543777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abdominal involvement in pediatric heart and lung transplant recipients with posttransplant lymphoproliferative disease increases the risk of mortality.
    Tai CC; Curtis JL; Szmuszkovicz JR; Horn MV; Ford HR; Woo MS; Wang KS
    J Pediatr Surg; 2008 Dec; 43(12):2174-7. PubMed ID: 19040929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmission of donor diseases: efforts to protect recipients and increase deceased donor organ transplants.
    Morris P; Monaco A
    Transplantation; 2008 Apr; 85(8 Suppl):S49-50. PubMed ID: 18425035
    [No Abstract]   [Full Text] [Related]  

  • 10. Malignancy after solid organ transplantation: an overview.
    Zafar SY; Howell DN; Gockerman JP
    Oncologist; 2008 Jul; 13(7):769-78. PubMed ID: 18614590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posttransplant lymphoproliferative disorder: a pictorial review.
    Burney K; Bradley M; Buckley A; Lyburn I; Rye A; Hopkins R
    Australas Radiol; 2006 Oct; 50(5):412-8. PubMed ID: 16981935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization and organ transplant donors and recipients.
    Grabenstein JD
    Pharm Pract Manag Q; 2001; 20(3):11-22. PubMed ID: 11291515
    [No Abstract]   [Full Text] [Related]  

  • 13. Lymphoproliferative disorder of donor origin in a liver transplant recipient: complete remission after drastic reduction of immunosuppression without graft loss.
    Cherqui D; Duvoux C; Plassa F; Gaulard P; Julien M; Fagniez PL; Dhumeaux D; Goossens M; Farcet JP
    Transplantation; 1993 Oct; 56(4):1023-6. PubMed ID: 8212183
    [No Abstract]   [Full Text] [Related]  

  • 14. Low viral load post-transplant lymphoproliferative disease localized within the tongue.
    Henry DD; Hunger SP; Braylan RC; Dharnidharka VR
    Transpl Infect Dis; 2008 Dec; 10(6):426-30. PubMed ID: 18657087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Living related donor kidney transplantation in Libya: a single center experience.
    Elusta A; Shawish T; Mishra A; Ajaj H; Milud N; Shebani A; Abdulmola TS; Altajori O; Ethuish EF
    Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):831-7. PubMed ID: 18711310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe lymphoproliferative disease and Kaposi sarcoma in transplant patients.
    Touraine JL; Garnier JL; Lefrancois N; Finaz de Villaine J; Dubernard JM; de Thé G; Lenoir G
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3197-8. PubMed ID: 2650450
    [No Abstract]   [Full Text] [Related]  

  • 17. Post-transplant lymphoproliferative disorders after heart or kidney transplantation at a single centre: presentation and response to treatment.
    Aversa SM; Stragliotto S; Marino D; Calabrese F; Rigotti P; Marchini F; Gambino A; Feltrin G; Boso C; Canova F; Soldà C; Mazzarotto R; Burra P
    Acta Haematol; 2008; 120(1):36-46. PubMed ID: 18797163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zoonoses in solid-organ and hematopoietic stem cell transplant recipients.
    Kotton CN
    Clin Infect Dis; 2007 Mar; 44(6):857-66. PubMed ID: 17304461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organ transplantation at the Medical University of Warsaw.
    Paczek L; Durlik M; Górski A; Krawczyk M; Szmidt J; Lao M; Walaszewski J; Rowinski W; Orlowski T
    Clin Transpl; 2005; ():145-52. PubMed ID: 17424732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell post-transplantation lymphoproliferative disorder, a rare and challenging late complication of solid organ transplantation.
    Afify Z
    Pediatr Transplant; 2008 Sep; 12(6):617-8. PubMed ID: 18346038
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.